Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07313306 · ClinicalTrials.gov registry record · NA

Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise

A NA study of Breast Cancer and Metastatic Breast Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT07313306: Recruiting NA study of Breast Cancer and Metastatic Breast Cancer, sponsored by UNC Lineberger Comprehensive Cancer Center.

NCT07313306 is a NA study of Breast Cancer and Metastatic Breast Cancer that is actively recruiting participants, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 50 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07313306, a NA study of Breast Cancer and Metastatic Breast Cancer, is actively recruiting participants, sponsored by UNC Lineberger Comprehensive Cancer Center.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This study will examine unmet exercise needs among patients with metastatic breast cancer (MBC) at UNC and assess whether participation in Get Real and Heel (GRH) can increase physical activity. The proposed research aims to improve multiple domains of well-being, quality of life, physical function, social support and reduce social isolation through a community based exercise intervention. By leveraging underutilized University of North Carolina Chapel Hill (UNC) resources, this work seeks to reduce barriers to accessibility, awareness, and appropriateness of exercise programming for this underserved population. Findings will help close the gap between patients' exercise needs, interest, and participation, with potential benefits for symptoms, functioning, and quality of life.

Primary Outcome

The proportion of consented patients who are successfully referred to the Get Real and Heel program and complete at least 24 sessions (32 total available; 2 sessions per week) in person.

Interventions

  • BEHAVIORAL The Real and Heel (GRH)

Study Locations (1)

North Carolina

  • Lineberger Comphrehensive Cancer Center at University of North Carolina at Chapel Hill - Chapel Hill

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-12-15
Est. Completion 2028-07-01
Phase NA

What NCT07313306 shows while recruiting

NCT07313306 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which The Real and Heel (GRH) is the first listed.

NCT07313306 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT07313306 about?

NCT07313306 is a clinical study titled "Feasibility of Symptom Management for Patients With Metastatic Breast Cancer to Increase Exercise". This study will examine unmet exercise needs among patients with metastatic breast cancer (MBC) at UNC and assess whether participation in Get Real and Heel (GRH) can increase physical activity. The proposed research aims to improve multiple domains of well-being, quality of life, physical function,...

What is the current status of trial NCT07313306?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-12-15. Estimated completion is 2028-07-01.

What conditions does trial NCT07313306 study?

This clinical trial studies the following conditions: Breast Cancer, Metastatic Breast Cancer.

What interventions are being tested in trial NCT07313306?

The interventions under investigation include: The Real and Heel (GRH) (BEHAVIORAL).

Who is sponsoring clinical trial NCT07313306?

This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07313306 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07313306's enrollment target sits among peer trials

50 789th of 1224 higher than 410 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07313306, the US trial registry maintained by the National Library of Medicine. NCT07313306 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.